Pozelimab

4 trials 2 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

1 Completed trials

1 Sponsors

9 Countries

Phase III

Phase III: 4

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Sponsors using this IMP

Regeneron Pharmaceuticals Inc. 4

All trials

4 total

A Study to Evaluate how Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) wh… Pending

2024-519709-37-00 Phase III 3 countries Regeneron Pharmaceuticals Inc.
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Phase III 7 countries Regeneron Pharmaceuticals Inc.
A Study in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment with Pozelimab + Cemdisira… Recruiting

2023-510336-36-00 Phase III 6 countries Regeneron Pharmaceuticals Inc.
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients with Paroxysmal Nocturnal… Ended

2023-509657-31-00 Phase III 6 countries Regeneron Pharmaceuticals Inc.

Showing 1–4 of 4 trials

← All drugs A–Z